Archana Mathur

Title: Archana Mathur - Innovator in Antiangiogenic Drug Development

Introduction

Archana Mathur is a prominent inventor based in Ghaziabad, India. She has made significant contributions to the field of pharmaceuticals, particularly in the development of antiangiogenic drugs. Her innovative work focuses on using peptides to treat and prevent angiogenesis, which is crucial in cancer treatment.

Latest Patents

Archana Mathur holds one patent related to her groundbreaking invention of antiangiogenic drugs. This invention pertains to the use of peptides, either individually or in combination, for treating and preventing angiogenesis. The patent also covers peptide analogs, specifically a combination referred to as MuJ-7, which serves as an anticancer drug. MuJ-7 is designed to restrict tumor growth and spread by inhibiting tumor angiogenesis. Additionally, it plays a role in inhibiting metastasis through its antiangiogenic activity across all types of cancers. The invention includes a pharmaceutical composition containing these peptides and outlines methods for treating humans and animals to cure or prevent angiogenesis.

Career Highlights

Throughout her career, Archana Mathur has demonstrated a strong commitment to advancing medical science through her research and innovations. Her work has the potential to significantly impact cancer treatment and improve patient outcomes.

Collaborations

Archana has collaborated with notable colleagues, including Rama Mukherjee and Manu Jaggi, to further her research and development efforts in the pharmaceutical field.

Conclusion

Archana Mathur is a trailblazer in the development of antiangiogenic drugs, with her innovative approaches paving the way for new cancer treatments. Her contributions to the field highlight the importance of research and collaboration in advancing medical science.